Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, reflecting a minor backend/metadata update to the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedIntroduces new help and navigation sections and a recruitment-status note; updates the Intervention/Treatment label and bumps the site revision to v3.6.0, replacing the older 'Intervention / Treatment' label and the v3.5.5 reference.SummaryDifference0.4%

- Check26 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the study record that likely reflects minor maintenance or backend updates.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor version update to the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s embedded revision/version label was updated from `v3.5.2` to `v3.5.3`, indicating a content-management or site release rather than an update to the clinical trial information.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.5.2 released. Previous version: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.